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Overexpression of amphiregulin (AR) has been linked to psoriasis in mouse and man. Since psoriasis is marked by
hyperproliferation of keratinocytes and loss of epidermal barrier function with inﬁltration of inﬂammatory cells into
the epidermis and dermis, we hypothesized that AR might contribute to the pathogenesis of psoriasis by affecting
the integrity of cell–cell junctions. We ﬁnd that there is a marked reduction of functional E-cadherin in psoriatic
lesions from both INV-AR mice and individuals with psoriasis. Total E-cadherin levels are dramatically reduced in
psoriatic lesions from INV-AR mice. Compared with normal skin, psoriatic lesions from individuals with psoriasis
exhibit downregulation of the cytoskeletal-associated triton-insoluble pool of E-cadherin and the appearance of an
80 kDa ectodomain fragment in the cytoplasmic triton-soluble pool. There is reduced immunohistochemical stain-
ing for E-cadherin in the basal epidermis of human psoriatic lesions. Moreover, there is enhanced transmigration of
human neutrophils through polarized epithelial cell monolayers of MDCK cells after administration of AR, but not
transforming growth factor-a, further supporting a specific role for AR in the pathogenesis of psoriasis.
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Both epidermal growth factor receptor (EGFR) and several
cognate ligands, transforming growth factor-a (TGFa), he-
parin-binding EGF-like growth factor and amphiregulin (AR),
are overexpressed in psoriatic epidermis (Elder et al, 1989;
Cook et al, 1992; Piepkorn, 1996; Zheng et al, 2003). It has
been suggested that ligand-induced overstimulation of the
EGFR may contribute to epidermal hyperplasia and/or the
delayed apoptosis of epidermal keratinocytes that has been
observed in this disease (Nanney et al, 1992; Wrone-Smith
et al, 1997; Sibilia et al, 2000). Evidence for active roles of
keratinocytes in the development of psoriasis includes tar-
geted overexpression of several unrelated gene products to
murine epidermis, bone morphogenetic protein 6, integrin
b-1, and stat3, as well as targeted disruption of leucine-rich
and immunoglobulin-like glycoprotein (Carroll et al, 1995;
Blessing et al, 1996; Suzuki et al, 2002, Sano et al, 2005).
Inappropriate expression of these diverse gene products
may lead to the disruption of normal keratinocyte differen-
tiation and subsequent stimulation of not only keratinocyte
hyperproliferation but also inflammatory cell infiltration and
generation of acquired immune responses. Of relevance to
this study, targeted expression of human AR to either the
basal epidermis (K14-ARGE) or suprabasal epidermis (INV-
AR) of transgenic mice triggers the development of a se-
vere, early-onset psoriatic-like phenotype (Cook et al, 1997;
Cook et al, 2004). Moreover, these AR expressing trans-
genic models produce an unexpected psoriatic-like inflam-
matory state and recapitulate almost all of the macroscopic
and microscopic features of human psoriasis, including
synovitis, a precursor to psoriatic arthritis (Cook et al, 2004).
Thus, AR may be unique in its ability to induce a severe and
complete psoriasis-like response that includes not only ep-
idermal hyperproliferation but also cutaneous and acral
(joint) inflammatory lesions.
In addition to disrupted keratinocyte differentiation and
hyperproliferation, loss of function of the epithelial barrier
that accompanies alterations of epithelial junctional mole-
cules, such as E-cadherin, P-cadherin, ZO-1, and occludin,
is associated with cutaneous epithelial inflammatory proc-
esses typified by psoriasis as well as gut-related barrier
disruption seen in inflammatory bowel disease (Matsuyoshi
et al, 1995; Gassler et al, 2001; Kucharzik et al, 2001;
Pummi et al, 2001; Zhou et al, 2003). In this regard, disrup-
tion of the intestinal mucosal barrier is suspected to play
a central role in the pathogenesis of inflammation. But to
date, there is no evidence that establishes a direct link be-
tween perturbation of cell junctions and AR expression in
psoriasis.
We hypothesized that AR affects the integrity of cell–cell
junctions. We examined junctional components in the in-
volved skin of INV-AR-transgenic mice and individuals with
Abbreviations: AR, amphiregulin; EGFR, epidermal growth factor
receptor; PMN, polymorphonuclear leukocytes; SDS, sodium do-
decyl sulfate; TGFa, transforming growth factor-a
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psoriasis by western blotting and immunohistochemistry.
We also compared the effects of recombinant human AR
and TGFa applied to the basal compartment of polarized
MDCK strain II (hereafter referred to as MDCK) cells on
transmigration of human neutrophils. These results demon-
strate that AR markedly alters E-cadherin expression, lo-
calization and processing in the epidermis of AR-transgenic
mice similar to that observed in the involved skin of indi-
viduals with psoriasis and that AR preferentially enhances
neutrophil transmigration in an in vitro model simulating in-
tact epithelial barrier function.
Results
Modulation of junctional proteins in INV-AR-transgenic
mice INV-AR mice have been reported to develop psoriatic
skin lesions (Cook et al, 2004). To investigate possible al-
terations of junctional molecules in these mice, punch bi-
opsies of the involved skin in INV-AR-transgenic mouse and
site-matched skin of a non-transgenic littermate were per-
formed (Fig 1A). For these studies, we examined the triton-
insoluble and triton-soluble pool of junctional proteins; the
former is tightly bound to the cytoskeleton and established
junctions, whereas the latter is not tightly associated with
the cytoskeleton. Immunoblotting of tissue lysates in the
triton-soluble fraction revealed that components of adher-
ens junctions (E-cadherin, P-cadherin, a- and b-catenin)
and tight junctions (ZO-1 and ZO-2) were downregulated in
the involved skin of the INV-AR mouse compared with site-
matched skin taken from a non-transgenic littermate (Fig
1B). The level of p120 also was reduced in the triton-soluble
pool (data not shown). Although total occludin levels in the
triton-soluble fraction were unchanged in both mice, the
hyperphosphorylated form of occludin (indicated by arrow-
head) that has been implicated in regulation of the tight
junctional barrier (Wong, 1997) was downregulated similar
to components of the adherens junctions in the skin of the
INV-AR mouse. In the triton-insoluble pool, E-cadherin was
also downregulated, but there was an increase in P-cad-
herin as has been reported recently in the basal epidermal
layer of mice with a conditional knockout of E-cadherin in
the skin (Tinkle et al, 2004) and in psoriatic epidermis (Zhou
et al, 2003).
Detection of truncated forms of E-cadherin and down-
regulation of functional E-cadherin in human psoriatic
tissues We next analyzed E-cadherin expression in human
psoriatic tissues in which AR has been shown to be upreg-
ulated (Cook et al, 1992; Piepkorn, 1996). Punch biopsies of
the skin were taken from three normal subjects and from the
involved skin of three individuals with psoriasis, and lysates
were prepared for western blotting with E-cadherin (Fig 2).
Western blotting of the triton-soluble pool of normal and
psoriatic skin with an antibody to the N-terminus of E-cad-
herin (HECD-1) showed a 120 kDa immunoreactive species
that represents full-length E-cadherin in both groups (Fig
2A). Of interest, a 80 kDa fragment of E-cadherin was sig-
nificantly increased in psoriatic skin. For the further analysis
of E-cadherin in normal and psoriatic skin, the pellet was
retrieved from the 1% Triton X-100 lysate and resolubilized
in 1% sodium dodecyl sulfate (SDS) lysis buffer. This triton-
insoluble pool of E-cadherin is thought to be tightly bound
to the cytoskeleton and established adherens junctions and
thus represents functional E-cadherin. Western blotting with
an antibody to the C-terminus of E-cadherin in the triton-
insoluble pool detected a 120 and 30 kDa fragment in
both normal and psoriatic skin. The C-terminal 30 kDa
E-cadherin fragment retains its cytoskeletal association and
corresponds to the N-terminal 80 kDa fragment in the triton-
soluble pool (Fig 2B).
The relative density of E-cadherin was plotted after nor-
malization to b-actin (Fig 2C). E-cadherin was downregu-
lated in psoriatic skin of two patients compared with normal
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Figure1
Modulation of junctionl proteins in INV-AR-transgenic mice. (A)
Punch biopsies of the involved skin in INV-AR-transgenic mice and site-
matched skin of a non-transgenic littermate were performed. (B)
Immunoblotting of tissue lysates in both triton-soluble and -insoluble
fractions were conducted with specific antibodies to component of
adherens junctions (E-cadherin, P-cadherin, a- and b-catenin) and tight
junctions (ZO-1, ZO-2, and occludin). The levels of adherens junctions
proteins and hyperphosphorylated forms of occludin, indicated by ar-
rowhead, were downregulated in the involved skin of the INV-AR mouse
compared with normal skin. AR, amphiregulin.
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skin. To further investigate adherens junctions in normal and
psoriatic skin, immunohistochemistry was performed with
specific antibodies for E-cadherin. E-cadherin immunore-
activity was detected uniformly within all layers of normal
epidermis at sites of cell–cell junctions (Fig 3A, left panel).
Magnified views of cell–cell contacts within the basal layer
and upper, granular layers of epidermis are shown. In con-
trast to uniform expression in normal epidermis, E-cadherin
immunoreactivity was altered in psoriasis. In the basal layer,
keratinocytes with uniformly reduced E-cadherin immuno-
reactivity were detected. Figure inset illustrates represent-
ative epidermal keratinocyte populations in the basal layer
of psoriasis with reduced immunoreactivity. In the mid-ep-
idermis, intact E-cadherin immunoreactivity at cell–cell con-
tact sites was observed. But downregulation of E-cadherin
was detected again in the upper, granular layers of ep-
idermis with the immunoreactive E-cadherin exhibiting a
punctate, discontinuous appearance. Thus, E-cadherin
expression was suppressed in both the basal and upper
layers of psoriatic epidermis. In conclusion, aberrant E-
cadherin expression was detected in the epidermis of pso-
riasis, which correlated with reduced E-cadherin levels in
the triton-insoluble pool.
Enhanced transmigration of polymorphonuclear leuko-
cytes (PMN) in AR-treated MDCK cells To more directly
link AR to the influx of neutrophils observed in psoriatic skin,
we established an in vitro transmigration assay with PMN
using polarized monolayers of MDCK cells as a cell culture
model of neutrophil migration in the skin. MDCK cells and
keratinocytes both form intact epithelial layers that polarize
and generate electrical resistance, but MDCK do not stratify,
allowing neutrophil transmigration to be measured more ac-
curately (Parkos et al, 1991; Kobayashi et al, 2004). In this
model, we compared the effects of recombinant human AR
and TGFa on facilitating neutrophil migration across MDCK
cells. PMN isolated from human blood were applied to the
apical chamber of MDCK cells to allow basolateral to apical
transmigration toward the chemoattractant, fMLP, in the
bottom of the chamber. In preliminary experiments over a
three-log concentration range of AR and TGFa (0.1–100 nM),
we determined that 10 nm AR was equipotent to 1 nM TGFa
as determined by tyrosine phosphorylation of the EGFR after
10 min exposure to these ligands (data not shown). Com-
pared with control or 1 nM TGFa-treated MDCK cells, PMN
transmigration increased 1.8-fold in 10 nM AR-treated
MDCK monolayers (Fig 4A). In addition, monoclonal anti-
body blockade of the EGFR prevented the AR-induced
transmigration of PMN. Thus, AR facilitates EGFR-depend-
ent transmigration of PMN across epithelial monolayers. In
separate experiments, there was a concentration-depend-
ent increase in transmigration with AR that was not ob-
served with TGFa (Fig 4B).
Figure2
Detection of truncated forms of E-cadherin and downregulation of
functional E-cadherin in human psoriatic tissues. (A) Punch biopsies
of the skin were taken from three normal subjects (N) and from the
involved skin of the three individuals with psoriasis (P). Lysates were
prepared for western blotting of E-cadherin. Western blotting of the
triton-soluble pool of normal and psoriatic skin with an antibody to the
N-terminus of E-cadherin (HECD-1) showed a 120 kDa immunoreactive
species that represents full-length E-cadherin and an 80 kDa fragment
that represents N-terminal truncated forms of E-cadherin. The 80 kDa
fragment of E-cadherin was significantly increased in psoriatic skin. (B)
The retrieved pellet from the 1% Triton X-100 lysate was resolubilized in
1% SDS lysis butter. This triton-insoluble pool of E-cadherin, bound to
the cytoskeleton, is thought to represent functional E-cadherin. West-
ern blotting with an antibody to the C-terminus of E-cadherin detected
a 120 and 30 kDa fragment in both normal and psoriatic skin. The
C-terminal 30 kDa E-cadherin fragment retains its cytoskeletal asso-
ciation and corresponds to the N-terminal 80 kDa fragment in the
triton-soluble pool. (C) Relative density of E-cadherin was plotted after
normalization to b-actin.
1136 CHUNG ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
To gain mechanistic insight into this selective effect of AR
on transmigration, we compared the effects of 10 nM AR
and 1 nM TGFa on cell–cell junctional events in MDCK cells.
Sixteen hours exposure to TGFa resulted in a greater in-
crease in electrical resistance than AR (Fig 5A). Previous
studies have shown that there is an inverse relationship be-
tween electrical resistance and claudin-2 levels. Consistent
with these studies, there was a greater decrease in claudin-
2 levels after TGFa treatment compared with AR (Fig 5B).
Moreover, MDCK cells exposed to 1 nM AR for 16 h resulted
in downregulation of ZO-1 and E-cadherin in the triton-sol-
uble fraction (Fig 5C), a finding similar to what was observed
in the skin of AR-transgenic mice (Fig 1B). In contrast,
treatment of MDCK with 1 nM TGFa for 16 h resulted in
upregulation of ZO-1 and E-cadherin.
Taken together, our data support a model in which AR
reduces levels of functional E-cadherin, resulting in an im-
paired junctional barrier and allowing transmigration of
PMN. This model may provide insight into an important
mechanism of action by which AR induces psoriatic inflam-
mation and contributes to the pathogenesis of psoriasis.
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Figure 3
Alterations of E-cadherin immuno-
reactivity in human psoriatic tissue.
Immunohistochemistry was performed
with specific antibodies for E-cadherin in
normal and psoriatic skin. Immunoreactiv-
ity of E-cadherin was detected uniformly
within all layers of normal epidermis at
sites of cell–cell junctions (left panel). Mag-
nified views of cell–cell contacts within the
basal layer and upper, granular layers of
epidermis are shown, indicated as (A) and
(B), respectively. Immunoreactivity of E-
cadherin was altered in psoriasis (right
panel). Downregulation of E-cadherin was
detected in the upper, granular layer of the
epidermis, which are magnified at the
bottom and indicated as (A0) and (B0),
respectively.
Figure4
Enhanced transmigration of polymorphonuclear leukocytes (PMN)
in amphiregulin (AR)-treated MDCK monolayers. (A) In vitro trans-
migration assays with PMN using polarized monolayers of MDCK cells
were performed and effects of recombinant human AR and transform-
ing growth factor-a (TGFa) were compared. PMN isolated from human
blood were applied to the apical chamber of MDCK cells to allow
transmigration toward the chemoattractant, fMLP, in the bottom of the
chamber. Compared with control or TGFa-treated MDCK cells, trans-
migration of PMN, as measured by myeloperoxidase activity, increased
1.8-fold in AR-treated MDCK cells. Monoclonal antibody blockade of
EGFR prevented AR-induced transmigration of PMN. (B) Concentra-
tion-dependent effects of AR and TGFa on PMN transmigration. PMN
transmigration was measured 2 h after administration of growth factors
and expressed as fold increase compared with control. The graph
represents the mean values  SE of triplicate samples from a repre-
sentative experiment performed three times.
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Discussion
Psoriasis is a genetic disorder that exhibits numerous mi-
croscopic, ultrastructural, and biochemical alterations with-
in the epidermis (McKay and Leigh, 1995; Pittelkow, 1998).
Some of the defects are mediated by infiltrating neutrophils
and lymphocytes, whereas other abnormalities are intrinsic
and may also reside within the uninvolved, non-lesional ep-
idermis (Pittelkow, 1998; Bhawan et al, 2004). We have fo-
cused attention on the epidermal changes that develop in
the setting of AR overexpression, both in the natural oc-
curring disease, psoriasis, and in AR-transgenic mice that
manifest a striking psoriasiform skin pathology.
Two distinct, epidermally targeted AR-transgenic mouse
strains develop many features of psoriasis spontaneously.
Pronounced epidermal hyperplasia, hyperkeratosis, and
parakeratosis, localized epidermal edema (spongiosis), ne-
utrophil infiltration into the epidermis, along with dermal and
epidermal lymphocyte accumulation in the skin are ob-
served in these mouse models. By comparison, various cell
culture, animal model and disease-based investigations
have demonstrated that elevated growth factor expression
and activation of receptor tyrosine kinases alter epidermal
and other epithelial cell–cell interactions and tissue perme-
ability (reviewed in Wheelock and Johnson, 2003; Harhaj
and Antonetti, 2004).
Molecular alterations in epidermal barrier function and
mechanisms underlying the perturbed state of proliferation
and differentiation in psoriatic epidermis remain poorly un-
derstood. Adherens junctions and tight junctions are critical
for normal epidermal barrier function as well as overall
homeostasis and have been shown to be altered in psoria-
sis (Pummi et al, 2001; Perez-Moreno et al, 2003; Zhou et al,
2003; Harhaj and Antonetti, 2004). In this investigation, we
compared the expression of adherens and tight junction
proteins in AR-transgenic mice and human psoriatic tissue
and show that E-cadherin is similarly downregulated in ep-
idermis of both pathologically involved tissues. We also
observed that levels of the tight junction proteins, ZO-1
and ZO-2, are downregulated in the involved skin of AR-
transgenic mice. We further demonstrate a specific func-
tional role for AR in transmigration of neutrophils that is not
shared by another EGFR ligand, TGFa, that is also overex-
pressed in psoriatic epidermis. Furthermore, we observed
that administration of recombinant human AR, but not TGFa,
results in redistribution of E-cadherin from a triton-insoluble
pool to a triton-soluble pool in MDCK cells (E. Chung and R.
J. Coffey, unpublished observations). Thus, we speculate
that increased basolateral to apical transmigration of ne-
utrophils through inverted monolayers of MDCK cells is
highly associated with E-cadherin modulation.
E-cadherin is normally expressed throughout the epider-
mis and virtually all epidermal keratinocytes. It represents the
main cadherin type responsible for intercellular adhesion of
keratinocytes (Wheelock and Jensen, 1992). Whereas loss of
E-cadherin is lethal in early embryogenesis, conditional gene
targeting of postnatal murine epidermis has revealed that
E-cadherin plays a critical role in keratinocytes adherence,
epidermal thickness, and differentiation (Young et al, 2003;
Tinkle et al, 2004). E-cadherin mutant mice showed
acanthosis, hyperkeratosis, widening of basal cell intercellu-
lar spaces and induction of K6 expression, findings that are
also characteristically observed in psoriatic epidermis (Stoler
et al, 1988; Pittelkow, 1998; Bhawan et al, 2004).
We, therefore, closely examined epidermis of lesional
psoriasis and normal skin for expression and localization
of E-cadherin. We demonstrate that E-cadherin is spatially
decreased in the epidermis of lesional psoriasis, specifically
in the basal cell and upper granular layers compared with
normal epidermis. Decreased expression of E-cadherin is
observed more so within the base and sides of the accen-
tuated rete pegs than the connecting arcades. These find-
ings contrast with the reported interpretation of E-cadherin
expression in psoriasis recently published by Zhou et al
(2003). But closer inspection of their Fig 1c and f indicates
diminished expression of E-cadherin in psoriatic epidermis.
Figure 5
Effects of amphiregulin (AR) and transforming growth factor-a
(TGFa) on junctional events. (A) Electrical resistance was determined
using a Millicell electrical resistance system after 16 h exposure to
10 nM AR and 1 nM AR added to the basolateral compartment of fully
polarized MDCK cells. The values represent the mean values  SE
(n¼ 4) from a representative experiment performed three times. (B) To-
tal cell lysates were prepared and western blotting performed for clau-
din-2 after treatment with AR and TGFa for the indicated times. (C) Total
cell lysates were prepared and western blotting performed for ZO-1
and E-cadherin after treatment with AR and TGFa for the indicated
times.
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Furthermore, soluble levels of E-cadherin have been quan-
titated in serum and are increased in psoriasis vulgaris,
correlating with disease severity (Matsuyoshi et al, 1995).
This finding may reflect increased proteolysis of cell surface
E-cadherin in the epidermis, therefore reducing functional
E-cadherin at the cell surface.
E-cadherin and P-cadherin are both expressed in epi-
dermis, but their expression appears to be independently
regulated in psoriatic epidermis. Zhou et al (2003)
demonstrated that expression of P-cadherin is increased
in psoriatic epidermal lesions. We observed that levels of P-
cadherin in the triton-insoluble fraction are increased as E-
cadherin levels decrease in AR-transgenic mice, similar to
that reported in psoriatic skin.
Both AR and TGFa are increased in involved psoriatic
epidermis (Elder et al, 1989; Cook et al, 1992). Both EGF
family ligands are potent mitogens for epidermal keratin-
ocytes. Alhough both AR- and TGFa-overexpressing mice
show epidermal hyperproliferation and acanthosis, only AR-
transgenic mice develop the marked inflammatory changes
of skin mimicking psoriasis (Vassar and Fuchs, 1991; Wang
et al, 1994; Cook et al, 1997, 2004). We reasoned that AR
specifically alters epidermal events that promote inflamma-
tion, including neutrophil and lymphocyte exocytosis into
epidermis. We tested the effects of AR compared with TGFa
on neutrophil transmigration in a well-established model
of an intact epithelial barrier, Transwell monolayer culture
of MDCK cells. AR stimulated an almost 2-fold greater ne-
utrophil transit across the intact monolayer than TGFa .This
finding provides evidence for the relative specificity of AR in
inducing and facilitating neutrophil migration into psoriatic
epidermis, at least, in part by disrupting adherens junctions.
We cannot exclude that other chemokines and chemoat-
tractants also upregulated in psoriatic epidermis may be
induced by enhanced expression of AR and participate in
generating the characteristic changes of neutrophil ex-
ocytosis seen in AR-driven psoriatic transgenic mice
and humans with psoriasis (Kulke et al, 1996, 1998). We
speculate that AR might act as a dual activity protein, pos-
sessing EGFR-mediated mitogenic activity and innate
immunogenic or pro-inflammatory activity that can stimu-
late both psoriatic epidermal hyperproliferation and psoria-
tic inflammation.
Materials and Methods
Reagents Cell culture reagents were purchased from Life Tech-
nologies (Carlsbad, California). Chemicals were purchased from
Sigma (St Louis, Missouri), unless otherwise stated. Transwell fil-
ters were purchased from Corning (Corning, New York). Rainbow
markers and ECL kit were purchased from Amersham Pharmacia
Biotech (Sunnyvale, California). Recombinant human AR and TGFa
were purchased from R&D Systems (Minneapolis, Minnesota).
Monoclonal antibody to human EGFR (mAb 528) was generously
provided by Dr Hideo Masui (Memorial Sloan-Kettering Cancer
Center, New York). Monoclonal antibodies to E-cadherin and ZO-2,
as well as a monoclonal antibody to P-cadherin, were purchased
from BD Pharmingen (San Diego, California). Polyclonal antibody
to b-catenin was purchased from Sigma. Polyclonal antibodies to
ZO-1, claudin-1, claudin-2, and occludin were obtained from
Zymed Lab (South San Francisco, California). Peroxidase-conju-
gated donkey anti-mouse IgG (HRP) and peroxidase-conjugated
donkey anti-rabbit IgG (HRP) were purchased from Jackson
Immunoresearch (West Grove, Pennsylvania).
Tissue preparation from mouse and human psoriatic tis-
sues Two millimeter punch biopsies were taken from the involved
skin of an INV-AR mouse (INV-AR founder 1) and site-matched
normal mouse skin from a non-transgenic littermate (Cook et al,
2004), as well as human normal and psoriatic skin. Acquisition of
human skin biopsies was approved by the Mayo Clinic Institutional
Review Board and biopsies performed after patient informed writ-
ten consent was obtained. The study was conducted according to
the Declaration of Helsinki Principles and was approved by the
Mayo Clinic ethical committee. For fractionation of a Triton X-100
soluble and insoluble pool, tissues were applied to 1% Triton X-100
buffer (1% Triton X-100, 100 mM NaCl, 10 mM HEPES, 2 mM EDTA
with 10 mg per mL aprotinin, 10 mg per mL leupeptin and 2 mM
PMSF) for lysis. After centrifugation, supernatants were collected
for triton-soluble pools and pellet was saved and applied to 1%
SDS buffer (1% SDS, 100 mM NaCl, 10 mM HEPES, 2 mM EDTA
with 10 mg per mL aprotinin, 10 mg per mL leupeptin, and 2 mM
PMSF). After sonication and incubation on ice for 20 min, this pellet
was centrifuged at 12,000g. This supernatant represents the triton-
insoluble pool. Twenty micrograms of total proteins was loaded for
SDS-PAGE and western blotting was performed with appropriate
antibodies.
Western blotting For western blotting, proteins were separated
by using 7.5% SDS-PAGE for E-cadherin and electrically trans-
ferred overnight at 30 V to nitrocellulose membrane (0.2 mm, Bio-
Rad). These membranes were subsequently rinsed with Tris-buff-
ered saline containing 0.5% Tween 20 (TBS-T), blocked for 1 h in
TBST containing 5% milk, and incubated with primary antibodies
for 2 h followed by incubation with horseradish peroxidase-con-
jugated secondary antibodies. Fluorography was performed using
BioMax MR film after detection using an ECL western blotting kit.
Immunohistochemistry Formalin-fixed, paraffin-embedded tis-
sue sections (5 mm) on glass slides were deparaffinized in xylene
and rehydrated through graded alcohol solutions. Sections were
incubated with 3% H2O2 for 20 min, and immunohistochemistry
was performed as reported previously (Matsui et al, 1990).
In vitro inﬂammation assay Normal human neutrophils were iso-
lated from non-coagulated, citrated blood by Ficoll–Paque density
sedimentation as per the manufacturer’s instructions (Amersham
Pharmacia Biotech). Neutrophils were suspended in modified
HBSS (Sigma-Aldrich, St. Louis, Missouri) containing 0.4 g per L
KCl, 0.06 g per L KH2PO4, 8 g per L NaCl, 0.048 g per L Na2HPO4,
0.01 g per L glucose, and 10 mM HEPES (pH 7.4) at 41C. For all
transmigration experiments, neutrophils were added to HBSS
containing 0.185 g per L CaCl2 and 0.0 98g per L MgSO4. Ne-
utrophil transmigration assays in the basolateral to apical direction
were performed as previously described in detail (Parkos et al,
1991) using inverted monolayers of MDCK cells. Briefly, the upper
reservoirs or basal compartments of Transwell apparati (5 mm pore
size, Corning) were filled with 150 mL of HBSS followed by the
addition of neutrophils (106 total neutrophils per inverted mono-
layer). Monolayers were then transferred to tissue culture wells
containing HBSS or 106 M fMLP and incubated for 2 h at 371C.
Neutrophils that had migrated through the monolayer and into the
lower reservoir were quantified by assaying for myeloperoxidase
activity as described previously (Parkos et al, 1991).
Cell culture and growth factor treatment MDCK cells were ob-
tained from Dr Enrique Rodrigues-Boulan (Cornell University Med-
ical College, New York). MDCK cells were cultured in DMEM
supplemented with 10% fetal bovine serum (Hyclone Laboratories,
Logan, Utah) as previously described (Dempsey and Coffey, 1994).
For culture on six-well dishes, cells were seeded at 5  105 and the
medium was changed every other day until cells reached conflu-
ence. For culture on Transwell filters (0.4-mm pore size, Corning),
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cells were seeded at 1  105 and 5  105 on 12- and 24-mm
Transwell filters, respectively, Medium was changed every other
day until transepithelial resistance was 4200 O per cm2 as meas-
ured by a Millicell electrical resistance system (Millipore Corp.,
Bedford, Massachusetts). Then recombinant human AR or TGFa
was added to the medium of cultures grown on plastic or to the
basal compartment of cells cultured on Transwell filters.
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